Pfizer to submit COVID-19 vaccine data in children in matter of 'days,' CEO says
(NEXSTAR) -- Pfizer's CEO says the company is close to submitting results of COVID-19 vaccine trials among children ages 5-11 in a bid to become the first vaccine maker to gain reg…
